Revenue | ₹5.91Cr |
Net Profits | ₹0.68Cr |
Net Profit Margins | 11.51% |
Aspira Pathlab & Diagnostics Ltd’s revenue jumped 51.93% since last year same period to ₹5.91Cr in the Q4 2024-2025. On a quarterly growth basis, Aspira Pathlab & Diagnostics Ltd has generated 7.45% jump in its revenue since last 3-months.
Aspira Pathlab & Diagnostics Ltd’s net profit jumped 236% since last year same period to ₹0.68Cr in the Q4 2024-2025. On a quarterly growth basis, Aspira Pathlab & Diagnostics Ltd has generated 119.35% jump in its net profits since last 3-months.
Aspira Pathlab & Diagnostics Ltd’s net profit margin jumped 189.52% since last year same period to 11.51% in the Q4 2024-2025. On a quarterly growth basis, Aspira Pathlab & Diagnostics Ltd has generated 104.14% jumped in its net profit margins since last 3-months.
The revenue for Aspira Pathlab & Diagnostics Ltd in the Q4 results 2024 was ₹5.91Cr.
The net profit for Aspira Pathlab & Diagnostics Ltd in the Q4 results 2024 was ₹0.68Cr.
The net profit margin for Aspira Pathlab & Diagnostics Ltd in the Q4 results 2024 was 11.51%.
The revenue for Aspira Pathlab & Diagnostics Ltd in the Q4 results 2023 was ₹3.89Cr.
The net profit for Aspira Pathlab & Diagnostics Ltd in the Q4 results 2023 was ₹0.50Cr.
The net profit margin for Aspira Pathlab & Diagnostics Ltd in the Q4 results 2023 was -12.85%.